Caris Life Sciences, Inc. Common Stock(CAI)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$18.60
52-Week Range
$14.19 – $42.50
YTD
-31.05%
IV Rank (30D)
66.2
Straddle Price
$2.70
P/C Vol Ratio
0.94
Market Cap
$5.3B
Fair Value
+40.6% vs price
Confidence: 35% Alpha Score: 0.67

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.50%
Beta vs SPY1.00
Cost of Equity (CAPM)10.00% (VRP-adj)
WACC9.67%
Volatility Risk Premium+103.2pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+19.2%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.10 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.1B
Return on Equity (TTM)-69.3%
Book / Price15.6%
Gross Margin (TTM)68.7%
FCF Margin (TTM)9.2%
Debt / Equity0.64
Quality Score2/6 — normal (10y DCF)
Market-Implied Growth+20.6% (reverse-DCF on current price)
SMA 50$17.66 (Market Anchor value)
SMA 20 / Bollinger Mid$17.30
Bollinger Width / SMA20112.3% (drives anchor stability)
Net Debt$-0.4B
Market Cap$4B
Peers used for multiples: ARWR, BMRN, GH, MRNA, NTRA, TWST, VCYT, VRTX
Blended Fair Value
$26.01
Current Price
$18.50
Deviation
+40.6%
Forward-Return Rank LONG gates ✓
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -3.8% -0.18 +0.48 56.0%
42d -4.1% +0.44 +0.79 65.6%
63d -3.2% +0.68 +0.91 69.0%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF $17.44 48%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 41.2× · 3 peers
Peer EV/EBITDA $19.73 14% median 26.4× · 3 peers
Peer P/B $18.22 19% median 6.2× · 7 peers
Peer P/S $60.63 19% median 12.3× · 8 peers
Market Anchor (SMA50) $17.66 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-26 · updated 2026-06-26 20:59:30.580000
Info
Industry (SIC)
SERVICES-MEDICAL LABORATORIES (8071)
Exchange
XNAS
Market Cap
$5.3B

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan -14.54% 1
Feb -11.90% 1
Mar -9.24% 1
Apr +0.58% 1
May -7.38% 1
Jun -0.24% 2
Jul +3.85% 1
Aug +0.34% 1
Sep -16.67% 1
Oct -0.20% 1
Nov -17.08% 1
Dec +10.43% 1
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $17.40
SMA 50: $17.61
SMA 200: $23.46
Current: $18.50
EMA 12: $17.88
EMA 26: $17.52
MACD: 0.3663 | Signal: 0.1666
BULLISH
ADX (14): 16.40
RANGE
+DI: 25.56
−DI: 13.37
Momentum Oscillators
RSI (14): 57.19
NEUTRAL
Stoch %K: 72.58
Stoch %D: 70.55
Williams %R: -35.09
Volume & Volatility
BB Upper: $19.13
BB Lower: $15.66
NEUTRAL
OBV: -5,057,965
Vol SMA 20: 2,864,160
Vol ROC: 203.96%
ATR: $1.14
True Range: $1.56
HV 20: 64.6%
HV 30: 62.6%
HV 60: 79.1%

Data Summary
Data Points: 257
Last Updated: 2026-06-26T21:15:25.978000
Date Range: 2025-06-18T00:00:00 – 2026-06-26T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Earnings History
4 of 5 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2025-08-12 After-Close 14.53% 7.73% 0.53x Within
2025-11-05 Pre-Market 19.56% 6.32% 0.32x Within
2026-01-12 Pre-Market 14.28% 9.34% 0.65x Within
2026-02-26 After-Close 22.85% 5.73% 0.25x Within
2026-05-07 After-Close 14.87% 18.09% 1.22x Exceeded
Options Activity
IV Rank (30D)
66.2
IV Rank (7D)
66.2
Avg IV
182.4%
Straddle (30D)
$2.70
Straddle (7D)
$2.70
P/C Volume
0.94
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.47
Correlation (SPY)
29.3%
0.09
Ann. Volatility
62.4%
SPY Volatility
12.5%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 202,974,613 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

202 filers151,040,314 shares$2.51B value74.41% of float
# Filer Shares Value % of Total % of Float Period
1 FMR LLC Custodian 30,785,585 $550.45M 21.95% 15.17% 2026-03-31
2 J. H. Whitney Equity Partners VI, LLC 18,256,615 $326.43M 13.02% 8.99% 2026-03-31
3 Sixth Street Partners Management Company, L.P. 14,385,399 $257.21M 10.26% 7.09% 2026-03-31
4 COATUE MANAGEMENT LLC 9,819,992 $175.58M 7.00% 4.84% 2026-03-31
5 BRAIDWELL LP 8,009,447 $143.21M 5.71% 3.95% 2026-03-31
6 PointState Capital LP 7,360,446 $131.60M 5.25% 3.63% 2026-03-31
7 BlackRock, Inc. Custodian 4,857,112 $86.85M 3.46% 2.39% 2026-03-31
8 Neuberger Berman Group LLC 3,590,586 $64.20M 2.56% 1.77% 2026-03-31
9 JPMORGAN CHASE & CO Custodian 3,460,215 $58.30M 2.33% 1.70% 2026-03-31
10 ORBIMED ADVISORS LLC 2,806,811 $50.19M 2.00% 1.38% 2026-03-31
11 UBS Group AG Custodian 2,745,811 $49.10M 1.96% 1.35% 2026-03-31
12 MORGAN STANLEY Custodian 1,794,991 $48.43M 1.93% 0.88% 2025-12-31
13 LOS ANGELES CAPITAL MANAGEMENT LLC 2,289,602 $40.94M 1.63% 1.13% 2026-03-31
14 BNP PARIBAS FINANCIAL MARKETS Custodian 1,614,286 $28.86M 1.15% 0.80% 2026-03-31
15 Clearbridge Investments, LLC 1,551,774 $27.75M 1.11% 0.76% 2026-03-31
16 FIL Ltd 1,546,091 $27.64M 1.10% 0.76% 2026-03-31
17 MILLENNIUM MANAGEMENT LLC Custodian 1,527,756 $27.32M 1.09% 0.75% 2026-03-31
18 CANADA PENSION PLAN INVESTMENT BOARD 1,322,752 $23.65M 0.94% 0.65% 2026-03-31
19 Invesco Ltd. Custodian 1,222,278 $21.85M 0.87% 0.60% 2026-03-31
20 Champlain Investment Partners, LLC 1,207,963 $21.60M 0.86% 0.60% 2026-03-31
21 Capital World Investors 1,180,173 $21.10M 0.84% 0.58% 2026-03-31
22 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME Custodian 1,149,133 $20.55M 0.82% 0.57% 2026-03-31
23 Point72 (DIFC) Ltd 654,792 $19.81M 0.79% 0.32% 2025-09-30
24 STATE STREET CORP 984,953 $17.61M 0.70% 0.49% 2026-03-31
25 Point72 Asset Management, L.P. 918,331 $16.42M 0.65% 0.45% 2026-03-31
6 filers$4.57M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $2.92M 63.82% 2026-03-31
2 JANE STREET GROUP, LLC Custodian $868.97K 19.01% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $266.41K 5.83% 2026-03-31
4 GROUP ONE TRADING LLC Custodian $241.38K 5.28% 2026-03-31
5 IMC-Chicago, LLC Custodian $228.86K 5.01% 2026-03-31
6 SIMPLEX TRADING, LLC Custodian $48.28K 1.06% 2026-03-31
7 filers$5.71M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $1.90M 33.38% 2026-03-31
2 Caption Management, LLC $1.79M 31.34% 2026-03-31
3 GROUP ONE TRADING LLC Custodian $683.02K 11.97% 2026-03-31
4 CITADEL ADVISORS LLC Custodian $665.14K 11.66% 2026-03-31
5 IMC-Chicago, LLC Custodian $337.93K 5.92% 2026-03-31
6 JANE STREET GROUP, LLC Custodian $239.59K 4.20% 2026-03-31
7 SIMPLEX TRADING, LLC Custodian $87.61K 1.54% 2026-03-31
Insider Activity
Latest: 2026-06-02
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-02 Jonathan Kenneth Charles Knowles Director Award (A) +1,600 $15.62 $25.0K EDGAR
2026-06-02 GEORGE POSTE Director Award (A) +1,600 $15.62 $25.0K EDGAR
2026-05-18 DAVID D HALBERT See Remarks Tax (F) −40,712 $15.25 -$620.9K EDGAR
2026-05-18 John Russel Denton See Remarks Tax (F) −6,047 $15.25 -$92.2K EDGAR
2026-05-18 Brian J Brille See Remarks Tax (F) −13,987 $15.25 -$213.3K EDGAR
2026-05-18 David Baxley Spetzler President Tax (F) −13,856 $15.25 -$211.3K EDGAR
2026-05-18 Luke Thomas Power See Remarks Tax (F) −9,771 $15.25 -$149.0K EDGAR
2026-05-12 Jeff L Vacirca Director Buy (P) +31,050 $16.15 $501.4K EDGAR
2026-03-10 DAVID D HALBERT See Remarks Award (A) +320,112 EDGAR
2026-03-10 Brian J Brille See Remarks Award (A) +83,162 EDGAR
2026-03-10 David Baxley Spetzler President Award (A) +83,162 EDGAR
2026-03-10 John Russel Denton See Remarks Award (A) +63,971 EDGAR
2026-03-10 Luke Thomas Power See Remarks Award (A) +63,971 EDGAR
2026-03-02 Lloyd Minor Director Award (A) +2,492 $20.06 $50.0K EDGAR
2026-02-27 PETER M CASTLEMAN Director Award (A) +5,509 $20.06 $110.5K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
54 insiders · @ $18.50
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 DAVID D HALBERT See Remarks 123,599,535 $2.29B $0 4 2026-05-18
2 J. H. Whitney Equity Partners VI, LLC 10%+ Owner 20,256,615 $374.75M $0 1 2025-06-23
3 Carisome I, L.P. 10%+ Owner 16,943,232 $313.45M $0 1 2025-06-23
4 PETER M CASTLEMAN Director 10,295,044 $190.46M $0 3 2026-02-27
5 Alan Waxman 3,493,789 $64.64M $0 1 2025-06-23
6 CLIFTON S ROBBINS 10%+ Owner 2,379,384 $44.02M $18.93M 1 2013-12-12
7 Blue Harbour Group, L.P. 10%+ Owner 2,344,414 $43.37M -$22.05M 2 2014-07-07
8 Andrew Ogawa 10%+ Owner 1,937,647 $35.85M -$53.95M 1 2018-02-22
9 JON HALBERT Director 743,621 $13.76M $0 2 2026-02-27
10 Brian J Brille See Remarks 730,303 $13.51M $630.0K 4 2026-05-18
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2025-12-11
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2025-12-11 LUKE POWER Officer 62,250 $1.69M 2025-12-11 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
Recent SEC Filings
Latest: 2026-06-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-06-05 0002019410-26-000046 EDGAR
2026-05-07 0002019410-26-000040 EDGAR
2026-04-02 0002019410-26-000019 EDGAR
2026-02-26 0002019410-26-000011 EDGAR
2026-01-12 0002019410-26-000005 EDGAR
2025-11-05 0002019410-25-000026 EDGAR
2025-10-30 0002019410-25-000020 EDGAR
2025-08-12 0002019410-25-000011 EDGAR
2025-06-20 0001104659-25-061148 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-03-03 0002019410-26-000016 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-08 0002019410-26-000044 EDGAR
2025-11-05 0002019410-25-000028 EDGAR
2025-08-12 0002019410-25-000012 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio8.9
P/S Ratio5.8
EV/EBITDA39.5
TTM Revenue$0.9B
TTM Net Income$-0.4B
TTM EPS$-6.28
ROE-69.3%
Debt/Equity0.64